InMode Ltd. (INMD)
InMode: My Pick For A Major Turnaround In 2026 And 2027
InMode Ltd. remains a global leader in minimally-invasive aesthetics, with proprietary RF and laser technologies and a strong international growth trajectory. I maintain a Strong Buy rating for INMD, citing undervaluation, robust free cash flow, a fortress balance sheet, and aggressive share repurchases. U.S. market saturation and sales execution remain challenges, but leadership changes and new product launches are driving positive cultural and operational shifts.
InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript
InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript
InMode (NASDAQ:INMD) Shares Gap Up – What’s Next?
InMode Ltd. (NASDAQ: INMD - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $12.76, but opened at $13.71. InMode shares last traded at $13.5850, with a volume of 653,419 shares changing hands. Wall Street Analysts Forecast Growth A number of research firms have recently weighed in on
InMode Ltd. (INMD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
InMode Ltd. (INMD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
InMode: Some Green Shoots Appearing, But The Market Hasn't Noticed
InMode Ltd. remains a Strong Buy at current levels, supported by a robust balance sheet, proprietary technology, and international growth. Green shoots include a 2.7% rise in consumables/servicing revenue and 14.5% international sales growth, offsetting possible U.S. market saturation. Management guides for flat 2026 revenue, with new product launches and expanding international footprint positioning INMD for future upside.
InMode Ltd. (INMD) Q4 2025 Earnings Call Transcript
InMode Ltd. (INMD) Q4 2025 Earnings Call Transcript
InMode's Shares Are Too Cheap To Ignore: The Bottom May Be In
InMode Ltd. remains a global leader in minimally invasive aesthetic medical devices, trading at a deep discount with a net cash position covering 58% of market cap. Despite a sharp 85% drawdown since 2021, INMD's robust balance sheet, strong FCF generation, and signs of improving fundamentals support a reiterated strong buy rating. Operational challenges—declining margins, inventory build, and sales execution—are offset by aggressive buybacks, high FCF yield, and significant upside if management improves capital allocation.
InMode Ltd. (INMD) Q3 2025 Earnings Call Transcript
InMode Ltd. ( INMD ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Moshe Mizrahy - Co-Founder, CEO & Director Yair Malca - Chief Financial Officer Conference Call Participants Miri Segal-Scharia - MS-IR LLC Danielle Antalffy - UBS Investment Bank, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Presentation Operator Good day, and welcome to InMode's Third Quarter 2025 Earnings Results Conference Call.
InMode: Discounted Valuation & Strong Fundamentals Make It A Buy
InMode presents an appealing buy opportunity, trading near 52-week lows with strong fundamentals, innovative technology, and global expansion. INMD's minimally invasive platforms drive revenue growth, with international markets and new product launches supporting diversification and future potential. Despite regulatory, tariff, and demand risks, INMD maintains robust margins, a strong cash position, and disciplined cost control, ensuring operational resilience.
InMode Ltd. (INMD) Q2 2025 Earnings Call Transcript
InMode Ltd. (NASDAQ:INMD ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Moshe Mizrahy - Co-Founder, CEO & Director Yair Malca - Chief Financial Officer Conference Call Participants Caitlin Cronin - Canaccord Genuity Corp., Research Division Danielle Joy Antalffy - UBS Investment Bank, Research Division Jeffrey D.
InMode (INMD) Q2 Earnings and Revenues Beat Estimates
InMode (INMD) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.34 per share a year ago.
InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
